It provides a subscription-based service focusing on prescription GLP-1 weight loss medications combined with clinical support
Treatment plans evolve through three phases: Initial metabolic reset using prescription therapies Custom-compounded solutions for sustained progress Long-term maintenance through lifestyle integration All medical weight loss protocols include nutrient deficiency testing and gut health assessments
In laboratory settings, GHK-Cu may be used to investigate: All uses are limited to research settings only
Supporting employees who take GLP-1 medications means recognizing that long-term wellness extends beyond weight loss alone and includes positive mental health
Whilst RCTs have reported DKA ranging from 0.84.3% [34], real-world rates of DKA have ranged from 0.0 [38]3.5% [25] with one outlier of 12.5% [14]
Everyones outcomes can vary, so watch for subtle changes in your energy, mood, or the fit of your clothes